Showing results (3251-3260 of 6,183) with videos related to
Sort By:
Pageof 619
Nature Medicine|October 13, 2021
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018Damaris Kinyoki, Aaron E Osgood-Zimmerman, Natalia V Bhattacharjee, et al.Nature Medicine|October 13, 2021
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan-Fung Yuen, Jeong Heo, Jeong-Won Jang, et al.Nature Medicine|October 19, 2021
Mutations and variants of ONECUT1 in diabetesAnne Philippi, Sandra Heller, Ivan G Costa, et al.Nature Medicine|October 19, 2021
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brainMegan S Keiser, Paul T Ranum, Carolyn M Yrigollen, et al.Nature Medicine|October 1, 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumorsRachna T Shroff, Pavani Chalasani, Ran Wei, et al.Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.Nature Medicine|March 22, 2022
Whole-genome risk prediction of common diseases in human preimplantation embryosAkash Kumar, Kate Im, Milena Banjevic, et al.Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.Nature Medicine|April 5, 2022
Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trialStephen R Russell, Arlene V Drack, Artur V Cideciyan, et al.Pageof 619